Cargando…
Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)
BACKGROUND: The relapse rate in early stage non-small cell lung cancer (NSCLC) after surgical resection is high. Prognostic biomarkers may help identify patients who may benefit from additional therapy. The Helicase-like Transcription Factor (HLTF) is a tumor suppressor, altered in cancer either by...
Autores principales: | Dhont, Ludovic, Pintilie, Melania, Kaufman, Ethan, Navab, Roya, Tam, Shirley, Burny, Arsène, Shepherd, Frances, Belayew, Alexandra, Tsao, Ming-Sound, Mascaux, Céline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902896/ https://www.ncbi.nlm.nih.gov/pubmed/29661164 http://dx.doi.org/10.1186/s12885-018-4215-y |
Ejemplares similares
-
Optimized application of penalized regression methods to diverse genomic data
por: Waldron, Levi, et al.
Publicado: (2011) -
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers
por: Arcolia, Vanessa, et al.
Publicado: (2014) -
Optimizing Drug Response Study Design in Patient-Derived Tumor
Xenografts
por: Weiss, Jessica, et al.
Publicado: (2022) -
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer
por: Wang, Dennis, et al.
Publicado: (2019) -
Collagen Type XI Inhibits Lung Cancer-Associated Fibroblast Functions and Restrains the Integrin Binding Site Availability on Collagen Type I Matrix
por: Zeltz, Cédric, et al.
Publicado: (2022)